Cacoullos NT - Search Results

1

Immunogenic HER-2/neu peptides as tumor vaccines.

Baxevanis CN, Sotiriadou NN, Gritzapis AD, Sotiropoulou PA, Perez SA, Cacoullos NT, Papamichail M. Baxevanis CN, et al. Among authors: cacoullos nt. Cancer Immunol Immunother. 2006 Jan;55(1):85-95. doi: 10.1007/s00262-005-0692-3. Epub 2005 Oct 27. Cancer Immunol Immunother. 2006. PMID: 15948002 Free PMC article. Review.

2

Vaccination with human HER-2/neu (435-443) CTL peptide induces effective antitumor immunity against HER-2/neu-expressing tumor cells in vivo.

Gritzapis AD, Mahaira LG, Perez SA, Cacoullos NT, Papamichail M, Baxevanis CN. Gritzapis AD, et al. Among authors: cacoullos nt. Cancer Res. 2006 May 15;66(10):5452-60. doi: 10.1158/0008-5472.CAN-05-4018. Cancer Res. 2006. PMID: 16707474

3

Effect of IL-21 on NK cells derived from different umbilical cord blood populations.

Perez SA, Mahaira LG, Sotiropoulou PA, Gritzapis AD, Iliopoulou EG, Niarchos DK, Cacoullos NT, Kavalakis YG, Antsaklis AI, Sotiriadou NN, Baxevanis CN, Papamichail M. Perez SA, et al. Among authors: cacoullos nt. Int Immunol. 2006 Jan;18(1):49-58. doi: 10.1093/intimm/dxh348. Epub 2005 Nov 15. Int Immunol. 2006. PMID: 16291655

4

A novel culture environment for generating mature human dentritic cells from peripheral blood CD14+ cells.

Tsiatas ML, Gritzapis AD, Cacoullos NT, Papadhimitriou SI, Baxevanis CN, Papamichail M. Tsiatas ML, et al. Among authors: cacoullos nt. Anticancer Res. 2001 Mar-Apr;21(2A):1199-206. Anticancer Res. 2001. PMID: 11396164

5

Induction of anti-tumour lymphocytes in cancer patients after brief exposure to supernatants from cultures of anti-CD3-stimulated allogeneic lymphocytes.

Baxevanis CN, Tsiatas ML, Cacoullos NT, Spanakos G, Liacos C, Missitzis I, Papadhimitriou SI, Papamichail M. Baxevanis CN, et al. Among authors: cacoullos nt. Br J Cancer. 1997;76(8):1072-80. doi: 10.1038/bjc.1997.510. Br J Cancer. 1997. PMID: 9376269 Free PMC article.

6

Mannose addition by yeast Pichia Pastoris on recombinant HER-2 protein inhibits recognition by the monoclonal antibody herceptin.

Vlahopoulos S, Gritzapis AD, Perez SA, Cacoullos N, Papamichail M, Baxevanis CN. Vlahopoulos S, et al. Vaccine. 2009 Jul 23;27(34):4704-8. doi: 10.1016/j.vaccine.2009.05.063. Epub 2009 Jun 9. Vaccine. 2009. PMID: 19520203

7

Efficacy of novel culture environments on the ex vivo expansion kinetics of cord blood progenitor cells.

Cacoullos NT, Gritzapis AD, Tsitsilonis AE, Tsiatas ML, Baxevanis CN, Papamichail M. Cacoullos NT, et al. Haematologica. 2002 Mar;87(3):320-1. Haematologica. 2002. PMID: 11869945

8

Cell mediated cytotoxicity assessment by relative changes in viable target absolute counts.

Topakas GN, Karchilaki IN, Cacoullos NT, Stavropoulos-Giokas C. Topakas GN, et al. Among authors: cacoullos nt. Immunopharmacol Immunotoxicol. 2001 Aug;23(3):459-75. doi: 10.1081/iph-100107344. Immunopharmacol Immunotoxicol. 2001. PMID: 11694035

9

Polyadenylated RNA sequences produced in vaccinia virus-infected cells under aberrant conditions inhibit protein synthesis in vitro.

Cacoullos N, Bablanian R. Cacoullos N, et al. Virology. 1991 Oct;184(2):747-51. doi: 10.1016/0042-6822(91)90445-h. Virology. 1991. PMID: 1716028

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page